These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 38386164)

  • 1. Impact of Immunosenescence in Older Kidney Transplant Recipients: Associated Clinical Outcomes and Possible Risk Stratification for Immunosuppression Reduction.
    Jallah BP; Kuypers DRJ
    Drugs Aging; 2024 Mar; 41(3):219-238. PubMed ID: 38386164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
    Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Need for optimized immunosuppression in elderly kidney transplant recipients.
    Lehner LJ; Staeck O; Halleck F; Liefeldt L; Bamoulid J; Budde K
    Transplant Rev (Orlando); 2015 Oct; 29(4):237-9. PubMed ID: 26411381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.
    Hahn D; Hodson EM; Hamiwka LA; Lee VW; Chapman JR; Craig JC; Webster AC
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004290. PubMed ID: 31840244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rationale for Age-Adapted Immunosuppression in Organ Transplantation.
    Krenzien F; ElKhal A; Quante M; Rodriguez Cetina Biefer H; Hirofumi U; Gabardi S; Tullius SG
    Transplantation; 2015 Nov; 99(11):2258-68. PubMed ID: 26244716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Belatacept for kidney transplant recipients.
    Masson P; Henderson L; Chapman JR; Craig JC; Webster AC
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010699. PubMed ID: 25416857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.
    Webster AC; Wu S; Tallapragada K; Park MY; Chapman JR; Carr SJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD004756. PubMed ID: 28731207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of immunosenescence on transplant outcome.
    Heinbokel T; Hock K; Liu G; Edtinger K; Elkhal A; Tullius SG
    Transpl Int; 2013 Mar; 26(3):242-53. PubMed ID: 23190423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion from Calcineurin Inhibitor- to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial.
    Budde K; Prashar R; Haller H; Rial MC; Kamar N; Agarwal A; de Fijter JW; Rostaing L; Berger SP; Djamali A; Leca N; Allamassey L; Gao S; Polinsky M; Vincenti F
    J Am Soc Nephrol; 2021 Dec; 32(12):3252-3264. PubMed ID: 34706967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute infections in kidney transplant recipients.
    Lys Z; Dombrovská K; Dědochová J; Kovářová P; Valkovský I; Václavík J
    Vnitr Lek; 2022; 68(E-3):12-17. PubMed ID: 36208913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 pneumonia in kidney transplant recipients: Focus on immunosuppression management.
    Chen TY; Farghaly S; Cham S; Tatem LL; Sin JH; Rauda R; Ribisi M; Sumrani N
    Transpl Infect Dis; 2020 Oct; 22(5):e13378. PubMed ID: 32573882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignancies in adult kidney transplant candidates and recipients: current status.
    Serkies K; Dębska-Ślizień A; Kowalczyk A; Lizakowski S; Małyszko J
    Nephrol Dial Transplant; 2023 Jun; 38(7):1591-1602. PubMed ID: 35998321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of age on rejection in kidney transplantation.
    de Fijter JW
    Drugs Aging; 2005; 22(5):433-49. PubMed ID: 15903355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Society for Maternal-Fetal Medicine Consult Series #66: Prepregnancy evaluation and pregnancy management of patients with solid organ transplants.
    ; Irani RA; Coscia LA; Chang E; Lappen JR;
    Am J Obstet Gynecol; 2023 Aug; 229(2):B10-B32. PubMed ID: 37088276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B; Tönshoff B
    Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul.
    Demir E; Uyar M; Parmaksiz E; Sinangil A; Yelken B; Dirim AB; Merhametsiz O; Yadigar S; Atan Ucar Z; Ucar AR; Demir ME; Mese M; Akin EB; Garayeva N; Safak S; Oto OA; Yazici H; Turkmen A
    Transpl Infect Dis; 2020 Oct; 22(5):e13371. PubMed ID: 32657540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basiliximab: a review of its use as induction therapy in renal transplantation.
    Chapman TM; Keating GM
    Drugs; 2003; 63(24):2803-35. PubMed ID: 14664658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction Versus Maintenance Immunosuppression After Intestinal Transplant: Determining Which Treatment Most Impacts Long-Term Patient And Graft Survival.
    Gentilini MV; Perez-Illidge L; Pedraza N; Nemirovsky SI; Fernandez MF; Ramisch D; Solar H; Rumbo M; Rumbo C; Gondolesi GE
    Exp Clin Transplant; 2022 Dec; 20(12):1105-1113. PubMed ID: 36718010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection.
    Marcén R
    Drugs; 2009 Nov; 69(16):2227-43. PubMed ID: 19852526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT.
    Haupenthal F; Rahn J; Maggi F; Gelas F; Bourgeois P; Hugo C; Jilma B; Böhmig GA; Herkner H; Wolzt M; Doberer K; Vossen M; Focosi D; Neuwirt H; Banas M; Banas B; Budde K; Viklicky O; Malvezzi P; Rostaing L; Rotmans JI; Bakker SJL; Eller K; Cejka D; Pérez AM; Rodriguez-Arias D; König F; Bond G;
    Trials; 2023 Mar; 24(1):213. PubMed ID: 36949445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.